Content area

Abstract

In recent years, industry has reduced its investment in U.S. biomedical research and development by billions of dollars, while increasing investment in Asia–Oceania. Thus, boosting U.S. government funding alone may be inadequate for retaining long-term R&D leadership.

Details

Title
Asia's Ascent — Global Trends in Biomedical R&D Expenditures
Author
Chakma Justin; Sun, Gordon H; Steinberg, Jeffrey D; Sammut, Stephen M; Jagsi Reshma 1 

 From Thomas, McNerney & Partners, La Jolla, CA (J.C.); the Robert Wood Johnson Foundation Clinical Scholars Program (G.H.S., R.J.), the Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System (G.H.S.), the Center for Bioethics and Social Sciences in Medicine (R.J.), and the Departments of Otolaryngology–Head and Neck Surgery (G.H.S.) and Radiation Oncology (R.J.), University of Michigan Health System — all in Ann Arbor; the Singapore Bioimaging Consortium, Agency for Science, Technology, and Research, Singapore (J.D.S.); and the Department of Health Care Management, Wharton School, University of Pennsylvania, Philadelphia (S.M.S.). 
Pages
3-6
Section
Perspective
Publication year
2014
Publication date
Jan 2, 2014
Publisher
Massachusetts Medical Society
ISSN
00284793
e-ISSN
15334406
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1473894767
Copyright
Copyright © 2014 Massachusetts Medical Society. All rights reserved.